TruAlt Bioenergy Stock Price Today (NSE: TRUALT)

TruAlt Bioenergy

506.55+11.35 (+2.29%)
Market Open

Fundamental Score

...

TruAlt Bioenergy Share Price — Live NSE/BSE Price, Fundamentals & Analysis

TruAlt Bioenergy share price today is 506.55, up +2.29% on NSE/BSE as of 19 June 2026. TruAlt Bioenergy (TRUALT) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of 3.60K (Cr). The 52-week high for TRUALT share price is 549.00 and the 52-week low is 310.20. At a P/E ratio of 28.29x, TRUALT is currently trading above its industry average P/E of 21.07x. The company has a Return on Equity (ROE) of 28.37% and a debt-to-equity ratio of 1.10.

TruAlt Bioenergy Share Price Chart — NSE/BSE Historical Performance

No data
High
508.00
Low
419.15
Volume
4.4L
Change
+2.68%

TruAlt Bioenergy share price chart: 2.68% return over the past month. 52-week high ₹549.00, 52-week low ₹310.20.

TruAlt Bioenergy — Last 10 Trading Days

DateOpenHighLowCloseVolume
495.90514.80489.05506.555.63L (Cr)
487.55507.00487.05495.204.46L (Cr)
497.00515.90480.25487.559.51L (Cr)
493.55493.55493.55493.550.00 (Cr)
494.95499.60491.05493.552.97L (Cr)
481.00498.00477.45491.855.47L (Cr)
440.00494.50419.15484.2028.91L (Cr)
480.85498.30479.30495.106.08L (Cr)
478.95489.00474.30478.151.62L (Cr)
465.00480.00458.00478.202.08L (Cr)

TruAlt Bioenergy — Last 12 Months Price History

MonthOpenHighLowCloseChange
487.55514.80487.05506.55+3.90%
497.90515.90419.15487.55-2.08%
414.00508.00399.00492.45+18.95%
389.00418.00357.00403.40+3.70%
374.25450.80362.20401.40+7.25%
406.75417.45310.20381.85-6.12%
448.95449.00384.00403.85-10.05%
446.40488.00401.85445.80-0.13%
545.40549.00439.25446.10-18.21%

AI Research Briefing

Powered by Gemini · 2026-04-13

Overvalued ethanol play dependent on continued government support and flawless execution of ambitious expansion plans, micro-cap liquidity a major risk.

Research Confidence
6.0/10Moderate
GOVT CAPEX DARK HORSEConsolidation - 1M: -5.99%.Expensive - P/E of 28.29x vs industry P/E of 21.07x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major catalysts found after live search. The last significant news was GAIL infusing Million in TruAlt Bioenergy's subsidiary Leafiniti on March 19, 2026. Lock-up agreements for 23,594,844 equity shares ended on March 31, 2026.

CORE STORY (THE REAL GAME)

Why Now
  • Ethanol blending mandates are supportive
  • CBG expansion offers high margins
  • SAF provides long-term optionality
Potential Catalysts
  • Favorable policy changes for ethanol blending
  • Successful commissioning of new CBG plants
  • Securing SAF funding and partnerships
Key Risks
  • Micro-cap liquidity risk
  • High debt and low-interest coverage
  • Promoter selling
Institutional Activity

Promoter selling (Δ -17.65%) signals caution. FII and DII holdings are relatively small, suggesting limited institutional interest.

Macro Context

Government focus on renewable energy and biofuel blending is a tailwind.

Order Book / Expansion

No major news found after live search.

Cash Flow Quality

No Free Cash Flow data available.

3–6 Month Outlook

Next 3-6 months hinge on CBG plant commissioning and progress on SAF project. Watch for policy announcements and execution updates.

Primary Thesis Risk

Policy reversal or execution delays could crater the stock.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Excellent

Return on Equity (ROE)

28.37%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

14.18%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

TruAlt Bioenergy Valuation Check

Poor

Price to Earnings (P/E)

28.29x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

21.07x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

70.55%

% shares held by company founders/management

Poor

FII Holding

1.30%

% shares held by foreign institutional investors

Average

DII Holding

7.80%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-103.32%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-70.41%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.10x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

2.11x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

TruAlt Bioenergy Fundamental Analysis & Valuation Benchmarking

Educational evaluation of TRUALT across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Strong Return on Equity (28.37%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Balanced Promoter Holding (70.55%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

6 factors identified

Profit Decline Concern (-103.32%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-70.41%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Elevated Debt Levels (D/E: 1.10)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Weak Interest Coverage (2.11x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Limited Institutional Interest (FII+DII: 9.10%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

TruAlt Bioenergy vs Other Agricultural Products Peers

Peer Comparison -

Compare TruAlt Bioenergy with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
0/100
507
₹3602.52
28.3
Average
28.37%
Excellent
14.18%
Average
1.1
Average
0.00%
LT Foods Ltd...
LTFOODS532783
67.8/100
405
₹14419.68
22.7
Average
16.70%
Good
19.18%
Good
0.4
Excellent
26.37%
Excellent
15.99%
Excellent
0.72%
KRBL Ltd...
KRBL530813
54.6/100
360
₹9182.57
15.1
Average
9.42%
Poor
11.84%
Average
0.0
Excellent
-3.15%
Poor
4.45%
Average
0.87%
44.1/100
160
₹5195.38
25.2
Average
8.59%
Poor
11.46%
Average
0.1
Excellent
10.42%
Good
3.86%
Average
0.22%
56.1/100
900
₹5132.36
16.9
Average
19.04%
Good
20.08%
Excellent
0.0
Excellent
3.36%
Average
5.30%
Good
0.50%
48.3/100
158
₹2915.20
43.0
Average
16.03%
Good
13.50%
Average
0.4
Excellent
13.84%
Good
12.44%
Good
0.00%
Sanstar Ltd...
SANSTAR544217
45.7/100
115
₹1641.27
81.7
Average
9.63%
Poor
11.76%
Average
0.0
Excellent
129.68%
Excellent
29.55%
Excellent
0.00%
42.3/100
280
₹1277.19
13.6
Average
14.19%
Average
16.71%
Good
0.1
Excellent
14.42%
Good
13.39%
Good
0.97%
52.7/100
98
₹1096.07
39.5
Average
28.81%
Excellent
21.16%
Excellent
0.3
Excellent
58.19%
Excellent
28.28%
Excellent
0.00%
57.2/100
69
₹1038.52
16.9
Average
9.89%
Poor
12.84%
Average
0.2
Excellent
7.46%
Good
7.00%
Good
1.03%
45.7/100
178
₹838.46
19.6
Average
3.92%
Poor
6.31%
Poor
0.7
Good
2.79%
Average
26.61%
Excellent
0.22%

TruAlt Bioenergy Quarterly Performance

Latest quarterly metrics for TRUALT — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-70.41%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-103.32%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

TruAlt Bioenergy Technical Indicators

SMA 50, SMA 200, RSI and volume signals for TRUALT — calculated from daily price history

56RSI 14
Neutral — RSI 56

Momentum is balanced — neither overbought nor oversold.

SMA 50
443
▲ Price above SMA 50 — Short-term bullish
30-Day Avg Volume
486K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

TruAlt Bioenergy Financial Statements

Annual income statement, balance sheet and cash flow for TruAlt Bioenergy (TRUALT) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for TruAlt Bioenergy

About TRUALT (TruAlt Bioenergy)

TruAlt Bioenergy (TRUALT) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Other Agricultural Products sector wi...th a current market capitalisation of ₹3.60K (Cr). TruAlt Bioenergy has delivered a Return on Equity (ROE) of 28.37% and a ROCE of 14.18%. The debt-to-equity ratio stands at 1.10, reflecting the company's capital structure. Investors tracking TRUALT share price can monitor key metrics including P/E ratio, promoter holding of 70.55%, and quarterly earnings growth.

Company Details

Symbol:TRUALT
Industry:Other Agricultural Products
Sector:N/A
Website:N/A

TRUALT Share Price: Frequently Asked Questions

What is the current share price of TruAlt Bioenergy?

TruAlt Bioenergy (TRUALT) trades at ₹506.55 on NSE and BSE. Market cap ₹3.60K (Cr). Educational data only.

What is the P/E ratio of TruAlt Bioenergy?

TruAlt Bioenergy has a P/E of 28.29x vs industry average 21.07x.

What is the Bull Run score for TruAlt Bioenergy?

TruAlt Bioenergy has a Bull Run score of 0/100 based on 25+ financial parameters.

Does TruAlt Bioenergy pay dividends?

TruAlt Bioenergy has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of TruAlt Bioenergy?

TruAlt Bioenergy has ROE of 28.37%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of TruAlt Bioenergy?

TruAlt Bioenergy has debt-to-equity of 1.10.

Is TruAlt Bioenergy a good investment?

Bull Run gives TruAlt Bioenergy a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.